Investors

Croda creates long-term value by engaging with our customers and markets wherever and whenever they need us - creating, making and selling sustainable and innovative speciality ingredients. We call this Smart science to improve lives™.

Find out more

Investors

We provide practical solutions to help address some of the world’s biggest challenges and are committed to becoming the most sustainable supplier of innovative ingredients. As part of this we will become Climate, Land and People Positive by 2030, having used the United Nations Sustainable Development Goals (SDGs) to underpin our approach.

This section tells you more about our goals, how we are achieving them, and the successes we have already achieved.

Visit our shareholder centre

Case study: Improving the customer experience in China

Our .CN website transformation, which was launched in 2020, has created an entirely new online experience for customers in fast-growing Chinese markets.

Financial performance and KPIs

View our most recent financial results and key performance indicators.

Find out more

Results, presentations and reports

View our results collateral and archive.

Find out more

Upcoming events and financial results

Health care investor seminar

We are hosting an investor seminar on our Health Care business on 7 October 2022. The in-person event will start at 08.30 BST, while the webcast of the event will begin at 09.30 BST. To register for the webcast, please use the registration button below. The live event has restricted capacity, however, if you would like to express an interest in attending in-person please contact investor.relations@croda.com

Half year 2022 results

Listen on demand to our half year results, 29 July 2022

Listen on demand

Investor news

Excellent first half performance driving profit growth

Sustainability expert Aris Vrettos joins Croda

The new position will see the sustainability expert challenge Croda to stretch its already industry-leading sustainability ambitions and commitments and support Croda’s business sectors in further...

UK Government to support expansion of Croda's lipid systems manufacturing facility

31 March 2022: This investment will significantly enhance the development of high-purity lipid systems, essential delivery systems for next generation nucleic acid drugs such as mRNA vaccines.

U.S. Government to support expansion of Croda lipid systems capability

Today we announce a joint investment with the U.S. government to expand our U.S manufacturing capacity for lipid systems used in novel therapeutic drugs, such as mRNA vaccines